Explore › Finding
Finding decline
Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly different between age groups.
Effect size81% vs. 28%
Follow-up3 years
ComparatorPediatric patients (n=18, 81% 3-year OS)
Effect summarydecline; 81% vs. 28%

Connected entities

Interventions
International neuroblastoma pathology classification: Favorable histology group, patient age 1.5 years up to but less than 5 years, with differentiating neuroblastoma (Schwannian stroma-poor), and low mitosis-karyorrhexis index
Conditions
Central nervous system
Outcomes
overall survival
Populations
Children

Source

PMC8711723
Prognostic factors for clinical outcomes of patients with central nervous system leukemia
Read on PMC → · View in graph →